Novavax Inc. Stock Falls Tuesday, Underperforms Market
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Novavax Inc. (NVAX) slid 4.77% to $9.79 Tuesday, on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ Composite Index falling 0.76% to 10,386.98 and Dow Jones Industrial Average falling 0.03% to 33,136.37. The stock's fall snapped a three-day winning streak. Novavax Inc. closed $131.98 short of its 52-week high ($141.77), which the company reached on January 4th.
The stock underperformed when compared to some of its competitors Tuesday, as Johnson & Johnson (JNJ) rose 0.87% to $178.19, Pfizer Inc. (PFE) rose 0.04% to $51.26, and Merck & Co. Inc. (MRK) rose 0.17% to $111.14. Trading volume (6.5 M) eclipsed its 50-day average volume of 6.3 M.
Data source: Dow Jones Market Data, FactSet. Data compiled Janurary 3, 2023.
(END) Dow Jones Newswires
January 03, 2023 17:14 ET (22:14 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.